Review By HARMINDER HARMY KAUR Last Updated On : Mar 13 2026 BSc(hons) Pharmacy GPhC Number: 2061107 Authored By GURDEV SEHMI Last Reviewed On : Mar 23 2026 BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead GPhC Number: 2050925
The well-documented association of postmeal hyperinsulinemia with massive GLP-1 secretion after RYGB [4] raised the possibility that this peptide contributes to enhanced prandial -cell function after this surgery
Drugs in R&D, 21 (2), 133-148.
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, though some specific formulations are now licensed for weight management in adults with obesity or overweight with weight-related comorbidities
Additionally, the growing cases of cardiovascular diseases and obesity are also contributing to their increased demand for GLP-1 drugs
GLP-1 Medications: These medications work by mimicking a hormone in your body that helps regulate blood sugar levels and appetite
